Sectors
KOD
Kodiak Sciences Inc.
99.87
2 x 30.95
2 x 55.16
bid
ask
+
5.61
5.95%
2 @ 07:57 PM
100.27 +0.40 (0.40%)
| Ytd | 257.19% | |
| 1y | 637.05% |
93.70
day range
100.30
11.60
52 week range
99.87
| Open | 94.64 | Prev Close | 94.26 | Low | 93.70 | High | 100.30 | Mkt Cap | 6.28B |
| Vol | 1.74M | Avg Vol | 1.57M | EPS | -4.19 | P/E | N/A | Forward P/E | -29.07 |
| Beta | 2.04 | Short Ratio | 17.79 | Inst. Own | 105.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 47.81 | 200-d Avg | 36.97 | 1yr Est | 116.67 |
| Income Statement | |||
| Operating Expenses | 66.84M | ||
| Research and Development Expense | 56.08M | ||
| Selling, General and Administrative Expense | 10.76M | ||
| Operating Income | -66.84M | ||
| Net Income | -65.64M | ||
| Net Income Common Stock | -65.64M | ||
| Net Income Common Stock (USD) | -65.64M | ||
| Consolidated Income | -65.64M | ||
| Earnings per Basic Share | -1.05 | ||
| Earnings per Basic Share (USD) | -1.05 | ||
| Earnings per Diluted Share | -1.05 | ||
| Earning Before Interest & Taxes (EBIT) | -65.64M | ||
| Earning Before Interest & Taxes (USD) | -65.64M | ||
| Weighted Average Shares | 62.63M | ||
| Weighted Average Shares Diluted | 62.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 132.09M | ||
| Cash and Equivalents (USD) | 132.09M | ||
| Current Assets | 131.36M | ||
| Property, Plant & Equipment Net | 110.61M | ||
| Total Assets | 256.81M | ||
| Debt Current | 9.81M | ||
| Total Debt | 152.76M | ||
| Current Liabilities | 52.77M | ||
| Debt Non-Current | 142.95M | ||
| Total Liabilities | 195.72M | ||
| Accumulated Retained Earnings (Deficit) | -1.68B | ||
| Shareholders Equity | 61.10M | ||
| Shareholders Equity (USD) | 61.10M | ||
| Assets Non-Current | 125.45M | ||
| Total Debt (USD) | 152.76M | ||
| Liabilities Non-Current | 142.95M | ||
| Trade and Non-Trade Payables | 12.64M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.19M | ||
| Net Cash Flow from Financing | 2.96M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -43.63M | ||
| Capital Expenditure | -352.00K | ||
| Issuance (Purchase) of Equity Shares | 2.96M | ||
| Net Cash Flow from Investing | -352.00K | ||
| Net Cash Flow from Operations | -46.24M | ||
| Share Based Compensation | 11.61M | ||